PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer. Sutera P, Kim J, Kumar R, Deek RA, et al. Prostate 2024 Jul 17. doi: 10.1002/pros.24765.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sutera P, Kim J, Kumar R, Deek RA, et al. PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer. Prostate 2024 Jul 17. doi: 10.1002/pros.24765.
PMID: 39021052